HKD 3.62
(0.28%)
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2023 | 1.07 Billion CNY | 74.42% |
2022 | 613.54 Million CNY | 134.43% |
2021 | 261.72 Million CNY | 5.96% |
2020 | 246.99 Million CNY | -18.79% |
2019 | 304.14 Million CNY | 4.82% |
2018 | 290.15 Million CNY | 0.0% |
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2024 Q2 | 1.64 Billion CNY | -0.0% |
2024 Q1 | 1.64 Billion CNY | 54.16% |
2023 Q2 | 793.94 Million CNY | 0.0% |
2023 FY | 1.07 Billion CNY | 74.42% |
2023 Q3 | 1.07 Billion CNY | 34.79% |
2023 Q4 | 1.07 Billion CNY | 0.0% |
2023 Q1 | 793.94 Million CNY | 29.4% |
2022 Q2 | 286.75 Million CNY | 0.0% |
2022 Q1 | 286.75 Million CNY | 9.56% |
2022 Q3 | 613.54 Million CNY | 113.96% |
2022 FY | 613.54 Million CNY | 134.43% |
2022 Q4 | 613.54 Million CNY | 0.0% |
2021 FY | 261.72 Million CNY | 5.96% |
2021 Q2 | 238.49 Million CNY | 0.0% |
2021 Q4 | 261.72 Million CNY | 0.0% |
2021 Q3 | 261.72 Million CNY | 9.74% |
2021 Q1 | 238.49 Million CNY | -3.44% |
2020 FY | 246.99 Million CNY | -18.79% |
2020 Q4 | 246.99 Million CNY | 0.0% |
2020 Q3 | 246.99 Million CNY | 0.0% |
2020 Q1 | - CNY | 0.0% |
2019 FY | 304.14 Million CNY | 4.82% |
2018 FY | 290.15 Million CNY | 0.0% |
Name | Total Liabilities | Total Liabilities Difference |
---|---|---|
Wai Chun Bio-Technology Limited | 229.69 Million HKD | -365.901% |
Lee & Man Chemical Company Limited | 1.22 Billion HKD | 12.941% |